drugset / Trial / NCT07076186
Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
NaSingle-groupOpen-labelTreatment
Summary
To find out if receiving standard chemotherapy (doxorubicin and trabectedin) can extend the cancer-free survival of patients with Stage 1b/2 uterine leiomyosarcoma who had surgery that fully removed the tumor.
Timeline
- Start
- 2025-10-02
- Primary completion
- 2027-12-02
- Completion
- 2029-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxorubicin | Other / unclassified | — | Intravenous |
| Subject | Trabectedin | Small molecule | — | Intravenous |